GELNOREX Trademark

Trademark Overview


On Wednesday, January 23, 2019, a trademark application was filed for GELNOREX with the United States Patent and Trademark Office. The USPTO has given the GELNOREX trademark a serial number of 88272921. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, September 1, 2025. This trademark is owned by Laboratorios Rangel C. por A.. The GELNOREX trademark is filed in the Pharmaceutical Products category with the following description:

Vitamin supplements
gelnorex

General Information


Serial Number88272921
Word MarkGELNOREX
Filing DateWednesday, January 23, 2019
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, September 1, 2025
Registration Number5821792
Registration DateTuesday, July 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements


Goods and ServicesVitamin supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 14, 2019
Primary Code005
First Use Anywhere DateSunday, November 20, 1994
First Use In Commerce DateFriday, February 17, 2006

Trademark Owner History


Party NameLaboratorios Rangel C. por A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDe La Vega
DO

Party NameLaboratorios Rangel C. por A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDe La Vega
DO

Party NameLaboratorios Rangel C. por A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDe La Vega
DO

Trademark Events


Event DateEvent Description
Wednesday, April 3, 2019ASSIGNED TO EXAMINER
Wednesday, April 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Saturday, January 26, 2019NEW APPLICATION ENTERED
Thursday, February 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 15, 2025TEAS SECTION 8 RECEIVED
Friday, August 29, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 1, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, September 1, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords


gelnorex supplements vitamin